rfhg_37779.1

Basic information about the TSS

---

TSS ID: rfhg_37779.1 TSS ID(Version3): hg_227938.1 hg_227939.1 hg_24826.1 Species: human Chr: chr2		Start: 206159866 End: 206159941 Strand: +
Source datasets	FANTOM5|PRJNA401781|PRJNA548673|PRJNA615891|DRA013844 |PRJDB5282|PRJNA597322|PRJNA4843412
Protocol	CAGE|oligo_capping|ReCappable-seq|TIF-seq2|C1CAGE|RAMPAGE |STRIPE-seq|SLIC_CAGE|NETCAGE
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3235725,EH38E2068916)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000392222.7:0 ENST00000415904.1:0 ENST00000435123.1:0 ENST00000455150.1:0 D28350:0 AK310096:0 AK291910:0 BC067787:0 BC029316:0 BC004931:0 GeneID: 1933 HGNC/MGI_ID: HGNC:3208 UniProt_ID: A0A024R3W7 F2Z2G2 F8WF65 F8WFC9 Nearer transcript ids and distances: AB529032:37 CU688340:38 JF432608:38 KJ891088:38 KJ905733:38 BT007079:39 CR456825:39 X60489:-121 ENST00000460760.1:-228 ENST00000429769.5:-230 BC000211:-238 ENST00000479587.1:-251 X60656:-256 NM_021121.4:-257 NM_001037663.2:-257 ENST00000445505.5:-259 S81522:-259 ENST00000392221.5:-272 ENST00000236957.9:-281 view more...

Gene_name: eukaryotic translation elongation factor 1 beta 2 Gene_symbol: EEF1B2 Gene_synonyms: Gene_source: HGNC:3208

TATA-Box annotation

---

Distance to TSS:	8
Nearest PromoterID:	NM_001959
Entrez ID:	1933
Nearest Unigene:	Hs.421608
Nearest Refseq:	NM_001959
Nearest Ensembl:	ENSG00000114942
Gene Name:	eukaryotic translation elongation factor 1 beta 2
Gene Alias:	EEF1B|EEF1B1|EF1B
Gene Type:	protein-coding
CpG%:	0.080000
GC%:	0.526316
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@EEF1B2 p2@EEF1B2 p3@EEF1B2 p4@EEF1B2
Sample		p1@EEF1B2	p2@EEF1B2	p3@EEF1B2	p4@EEF1B2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	221.30	113.18	24.74	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	198.88	109.45	19.42	2.43
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	208.92	110.92	26.62	1.93
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	183.58	86.70	17.46	2.29
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	178.40	91.34	17.55	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	172.10	85.47	16.86	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	233.14	154.26	18.52	1.53
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	197.65	135.89	18.89	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	184.01	131.65	18.17	1.71
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	286.91	223.74	16.23	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	258.71	194.84	13.74	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	228.08	187.83	15.45	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	297.40	32.88	1.93	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	254.39	23.45	2.71	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	313.52	27.22	2.63	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	300.28	24.90	2.51	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	278.25	21.40	3.71	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	246.76	24.89	4.64	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	307.10	17.06	3.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	348.27	33.25	3.61	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	270.11	27.67	4.01	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	295.70	33.83	2.93	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	264.59	21.46	3.10	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	291.20	25.24	3.15	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	325.84	26.83	3.35	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	318.73	35.13	2.22	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	290.11	17.58	7.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	317.79	31.83	1.41	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	249.55	25.04	2.42	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	291.54	31.85	2.90	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	265.87	28.47	3.35	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	278.03	27.55	3.91	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	242.89	21.52	3.38	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	304.31	29.03	3.30	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	340.32	28.42	2.06	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	270.00	24.72	3.64	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	301.05	36.38	3.88	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	277.25	25.79	2.22	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	352.75	37.81	2.43	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	296.24	35.29	2.64	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	257.61	25.88	1.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	285.76	33.67	4.25	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	418.20	36.91	4.43	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	293.01	33.22	4.55	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	319.23	36.54	4.62	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	322.22	37.22	4.42	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	343.31	38.86	2.88	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	326.96	41.73	4.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	320.52	39.02	3.35	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	335.24	38.22	3.24	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	344.94	35.46	5.33	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	350.24	40.69	6.67	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1441.19	209.88	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	339.95	35.84	3.90	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	276.37	31.48	4.64	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	527.69	52.01	15.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	357.29	43.17	3.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	354.90	34.03	6.16	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	346.86	37.26	4.50	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	422.77	53.75	6.92	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	358.87	37.37	6.35	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	308.43	35.89	6.73	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	302.53	37.42	8.76	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	357.10	36.36	7.14	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	379.18	42.56	4.55	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	307.06	23.43	2.48	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1584.07	161.64	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1397.85	86.87	15.79	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	304.21	26.33	4.88	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	348.60	25.79	5.95	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	276.78	20.17	5.16	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	313.64	19.87	4.64	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	253.97	26.60	4.64	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	276.09	17.43	2.75	0.61
Adipocyte - breast, donor1	11376-118A8	180.56	46.56	7.13	0.48
Adipocyte - breast, donor2	11327-117E4	155.93	47.81	6.10	0.32
Adipocyte - omental, donor1	11473-119C6	114.63	43.38	4.45	0.00
Adipocyte - omental, donor2	11474-119C7	165.94	43.35	7.47	0.75
Adipocyte - omental, donor3	11475-119C8	137.32	43.87	0.33	0.67
Adipocyte - perirenal, donor1	11476-119C9	258.39	56.14	6.38	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	131.94	35.18	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	321.56	45.16	9.03	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	413.93	30.24	3.48	1.39
Adipocyte differentiation, day04, donor1	13019-139D4	172.10	20.14	2.15	1.17
Adipocyte differentiation, day04, donor2	13022-139D7	163.18	17.50	4.89	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	174.79	27.88	5.30	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	166.35	15.28	4.70	2.35
Adipocyte differentiation, day08, donor1	13020-139D5	116.55	43.92	2.25	0.88
Adipocyte differentiation, day08, donor2	13023-139D8	163.96	28.08	5.49	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	177.02	19.19	1.60	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	154.13	25.04	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	92.33	39.93	1.25	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	106.24	29.39	2.01	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	112.57	26.83	1.64	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	78.55	32.58	2.44	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	181.44	74.92	11.93	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	64.54	20.08	2.51	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	91.05	9.58	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	170.55	35.80	0.72	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	197.47	16.73	3.35	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	169.90	37.80	1.23	0.82
Anulus Pulposus Cell, donor1	11248-116E6	365.25	43.83	3.43	1.03
Anulus Pulposus Cell, donor2	11463-119B5	349.73	31.35	1.71	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	280.36	40.89	8.54	2.70
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	300.86	42.98	9.99	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	351.00	40.66	8.56	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	299.22	54.40	8.67	1.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	337.66	41.73	11.38	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	263.37	39.60	7.26	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	257.31	36.71	10.72	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	280.10	47.57	7.77	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	303.47	40.98	6.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	308.09	46.33	12.05	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	298.98	44.99	9.43	2.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	287.11	36.36	7.52	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	247.10	44.97	6.10	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	271.60	62.78	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	311.08	44.48	8.90	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	270.57	53.58	5.89	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	296.25	44.21	8.69	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	245.10	30.47	10.16	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	249.72	44.87	1.95	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	289.92	42.79	6.97	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	288.17	40.82	7.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	297.37	56.64	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	272.90	39.97	6.52	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	226.53	50.34	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	298.54	44.66	15.05	2.91
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	344.54	50.47	7.59	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	258.02	38.76	4.85	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	311.24	55.29	8.55	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	268.50	41.90	4.70	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	261.70	38.97	9.29	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	283.87	45.51	6.57	1.88
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	268.82	35.05	7.40	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	328.19	38.53	7.85	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	289.55	48.55	8.19	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	298.06	39.44	8.43	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	286.31	38.02	10.69	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	357.01	52.89	13.22	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	340.77	46.86	14.01	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	321.50	34.95	9.53	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	289.13	52.22	6.04	2.59
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	279.43	41.28	8.47	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	256.34	43.50	8.41	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	242.80	51.96	7.56	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	261.58	42.89	8.98	1.36
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	250.17	34.75	9.27	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	219.71	69.71	6.34	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	271.87	38.17	6.00	1.29
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	281.58	34.29	11.43	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	280.66	46.65	7.29	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	303.90	48.28	10.11	2.30
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	265.23	33.15	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	337.11	51.86	9.15	1.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	266.72	43.97	8.26	1.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	251.84	36.72	9.49	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	316.44	41.59	12.91	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	273.63	38.80	8.20	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	360.09	42.72	10.68	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	317.93	48.19	6.09	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	255.26	42.90	9.27	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	285.31	34.16	8.00	0.73
Astrocyte - cerebellum, donor1	11500-119F6	136.94	53.92	2.82	0.86
Astrocyte - cerebellum, donor2	11580-120F5	143.77	42.79	3.25	1.03
Astrocyte - cerebellum, donor3	11661-122F5	102.99	19.30	2.10	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	254.12	97.95	5.93	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	233.28	91.08	13.27	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	243.58	102.32	14.62	1.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	382.59	72.48	17.20	1.72
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	365.20	82.06	27.56	1.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	350.95	83.64	20.37	1.25
Basophils, donor1	12241-129G9	301.29	18.05	2.09	0.78
Basophils, donor2	12242-129H1	426.46	25.98	3.97	0.72
Basophils, donor3	12243-129H2	224.46	16.90	1.18	1.18
Bronchial Epithelial Cell, donor1	11511-119G8	173.56	18.11	1.51	1.72
Bronchial Epithelial Cell, donor2	11591-120G7	28.80	7.77	0.46	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	358.68	28.69	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	293.11	55.86	15.69	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	201.92	45.96	8.11	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	305.83	51.59	4.38	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	349.81	42.65	6.30	1.62
Burkitt's lymphoma cell line:DAUDI	10422-106C8	614.42	78.84	10.10	2.37
Burkitt's lymphoma cell line:RAJI	10476-106I8	881.77	136.25	17.23	2.10
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	2391.60	60.44	24.94	12.47
CD133+ stem cells - cord blood derived, pool1	12223-129E9	1747.79	62.05	10.34	20.68
CD14+ Monocytes, donor1	11224-116B9	224.86	12.40	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	238.68	10.95	1.86	0.37
CD14+ Monocytes, donor3	11381-118B4	252.03	10.76	1.54	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	153.98	19.25	0.85	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	157.32	15.16	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	125.25	16.44	1.31	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	232.00	15.47	0.87	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	238.38	11.77	1.81	1.81
CD14+ monocytes - mock treated, donor3	11883-125D2	195.91	12.56	0.71	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	169.57	12.72	0.50	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	204.52	9.11	0.83	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	196.36	12.15	1.49	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	179.75	9.59	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	262.27	10.50	1.96	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	341.03	17.41	2.61	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	204.86	9.37	0.47	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	284.08	10.56	2.11	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	293.98	11.09	2.22	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	206.46	12.05	1.19	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	220.10	11.57	1.60	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	322.08	16.66	1.87	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	253.72	12.13	0.92	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	237.06	9.05	1.58	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	200.34	11.35	1.75	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	179.69	12.10	0.54	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	295.71	14.83	1.40	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	226.82	13.89	2.52	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	204.29	10.29	0.92	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	219.81	5.28	1.76	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	190.41	6.58	1.75	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	190.42	11.86	0.70	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	239.36	8.55	2.97	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	319.01	15.52	0.65	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	187.95	8.60	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	265.64	8.11	1.62	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	291.15	9.05	2.09	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	406.94	31.39	4.14	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	437.27	31.65	1.62	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	518.58	36.61	2.38	1.30
CD14+CD16- Monocytes, donor1	11788-124B6	354.73	30.37	1.87	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	329.38	28.47	0.52	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	221.41	19.40	1.34	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	621.86	41.59	3.06	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	370.19	32.50	2.42	2.20
CD14-CD16+ Monocytes, donor3	11911-125G3	448.67	34.53	2.32	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	2148.15	26.42	10.16	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	1928.17	29.83	13.56	5.42
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	1922.07	31.07	8.28	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	2221.17	39.98	9.59	4.26
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	2240.76	31.63	12.87	6.43
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	1799.77	19.65	9.13	4.21
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	1837.74	26.67	8.63	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	2407.19	30.32	14.50	6.59
CD19+ B Cells, donor1	11544-120B5	867.93	18.90	3.29	4.11
CD19+ B Cells, donor2	11624-122B4	947.41	13.06	5.80	5.80
CD19+ B Cells, donor3	11705-123B4	761.78	19.69	2.02	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	338.20	120.41	8.08	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	371.13	116.25	8.79	2.40
CD34+ Progenitors, donor1	11545-120B6	1552.26	33.13	7.03	5.02
CD34+ Progenitors, donor2	11625-122B5	1155.64	44.38	2.81	6.74
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	1607.10	67.26	19.54	8.27
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	2054.38	80.05	19.62	10.15
CD4+ T Cells, donor1	11225-116C1	786.24	13.21	8.21	5.36
CD4+ T Cells, donor2	11306-117C1	1140.83	11.02	12.86	3.06
CD4+ T Cells, donor3	11382-118B5	784.44	14.03	10.37	3.66
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	623.29	20.42	5.36	3.06
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	698.95	17.74	6.06	3.82
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	561.41	13.51	2.59	2.30
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	2323.52	21.81	13.27	5.69
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	2994.00	23.18	6.32	11.94
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	1648.11	29.67	13.18	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	328.77	24.13	4.62	4.05
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	536.18	23.39	7.80	4.07
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	407.37	24.18	7.42	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	829.80	24.21	8.07	6.72
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	887.80	24.81	6.29	6.64
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	538.54	19.80	5.72	2.64
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	568.79	21.93	4.64	5.48
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	515.06	21.40	7.48	3.12
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	614.46	24.39	6.01	2.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	1488.03	14.96	10.33	7.61
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1995.34	16.08	8.58	16.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1396.92	17.93	5.38	7.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	590.40	31.52	8.34	4.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	405.72	21.66	3.90	3.47
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	313.13	25.64	4.62	1.89
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	1661.92	16.68	10.62	9.10
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	1447.06	22.96	13.86	9.53
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	849.84	20.92	6.54	10.02
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	2268.48	16.33	9.40	6.43
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	2265.50	24.00	5.54	10.16
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	2441.29	26.52	9.77	9.77
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	1530.03	16.06	3.88	14.12
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	1375.91	19.39	3.44	6.87
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	1472.25	15.40	4.62	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	1553.87	15.04	8.24	6.09
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	2073.33	19.39	13.85	2.77
CD8+ T Cells, donor1	11226-116C2	734.35	15.71	11.13	1.64
CD8+ T Cells, donor2	11307-117C2	577.41	13.14	12.39	1.88
CD8+ T Cells, donor3	11383-118B6	894.57	14.90	9.34	1.77
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	162.64	30.97	29.36	2.52
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	152.65	25.64	25.88	1.92
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	149.65	28.18	27.63	3.56
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	205.64	41.13	36.03	6.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	168.71	33.60	24.48	3.60
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	164.85	34.56	22.28	3.41
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	178.82	35.85	36.72	3.26
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	173.98	30.27	29.22	3.95
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	145.40	28.38	30.02	1.64
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	165.73	28.98	27.17	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	177.21	29.63	24.69	2.32
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	148.14	34.37	29.31	3.20
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	133.08	7.88	13.57	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	121.14	11.39	19.13	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	114.86	8.20	12.68	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	142.26	34.94	30.97	3.96
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	155.37	29.35	17.84	2.59
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	137.65	28.28	14.38	2.36
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	138.80	30.11	43.73	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	167.01	28.30	38.75	2.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	144.26	28.85	31.42	4.17
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	136.16	29.07	26.39	2.68
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	148.97	27.59	26.01	2.36
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	149.01	20.42	18.91	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	127.67	20.88	33.72	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	125.20	13.29	32.87	3.50
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	105.18	15.03	42.07	2.00
Cardiac Myocyte, donor1	11525-119I4	95.04	5.48	5.48	0.00
Cardiac Myocyte, donor2	11605-120I3	215.42	41.01	7.91	1.98
Cardiac Myocyte, donor3	11686-122I3	276.97	38.52	4.53	1.89
Chondrocyte - de diff, donor1	11261-116G1	240.24	42.64	1.04	0.69
Chondrocyte - de diff, donor2	11338-117F6	342.94	39.45	3.91	2.49
Chondrocyte - de diff, donor3	11410-118E6	265.22	35.16	3.64	1.14
Chondrocyte - re diff, donor2	11339-117F7	261.41	42.08	12.53	1.79
Chondrocyte - re diff, donor3	11411-118E7	239.41	35.59	6.87	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	312.49	65.53	10.10	1.72
Ciliary Epithelial Cells, donor2	11323-117D9	278.54	66.27	11.54	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	235.32	58.85	9.65	1.15
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	97.29	33.38	1.38	0.00
Corneal Epithelial Cells, donor1	11526-119I5	89.81	16.47	1.54	0.66
Corneal Epithelial Cells, donor2	11606-120I4	169.50	29.58	4.55	3.41
Corneal Epithelial Cells, donor3	11687-122I4	155.17	28.37	4.09	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	104.01	19.81	1.65	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	135.94	24.92	1.58	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	165.63	17.25	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	101.73	18.25	1.40	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	700.02	50.22	3.07	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1252.21	86.18	4.57	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	886.59	56.62	2.42	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	435.10	50.53	14.68	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	335.64	41.66	11.15	2.93
Endothelial Cells - Aortic, donor2	11340-117F8	254.23	37.61	6.50	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	279.55	43.64	9.44	0.39
Endothelial Cells - Artery, donor1	11264-116G4	209.14	38.98	8.14	0.29
Endothelial Cells - Artery, donor2	11341-117F9	187.75	40.00	13.18	0.24
Endothelial Cells - Artery, donor3	11413-118E9	323.09	51.37	14.73	2.10
Endothelial Cells - Lymphatic, donor1	11236-116D3	270.86	29.26	3.99	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	139.66	22.21	2.43	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	113.89	20.58	3.38	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	179.47	34.17	4.46	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	505.57	57.27	10.41	2.08
Endothelial Cells - Microvascular, donor3	11414-118F1	154.26	22.12	1.28	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	244.47	56.82	8.40	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	245.81	36.69	5.77	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	281.79	51.56	14.91	0.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	214.65	33.46	8.26	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	209.57	42.50	11.85	0.49
Endothelial Cells - Vein, donor1	11267-116G7	305.99	52.33	13.65	1.14
Endothelial Cells - Vein, donor2	11344-117G3	236.09	46.80	4.89	1.40
Endothelial Cells - Vein, donor3	11416-118F3	248.23	49.93	7.38	0.47
Eosinophils, donor1	12244-129H3	853.83	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	130.37	13.20	0.00	1.65
Eosinophils, donor3	12246-129H5	85.60	7.13	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	124.12	19.06	4.15	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	164.33	14.56	2.08	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	113.88	81.34	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	302.96	43.51	8.21	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	156.90	35.69	3.50	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	282.44	36.29	3.14	0.98
Fibroblast - Aortic Adventitial, donor1	11245-116E3	224.00	58.34	13.95	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	86.52	36.85	6.82	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	223.28	40.08	6.01	1.48
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	139.91	35.31	12.38	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	253.80	48.17	9.97	0.66
Fibroblast - Cardiac, donor1	11268-116G8	242.69	45.36	9.53	0.45
Fibroblast - Cardiac, donor2	11345-117G4	241.79	45.48	7.58	0.00
Fibroblast - Cardiac, donor3	11417-118F4	118.29	33.59	6.78	0.32
Fibroblast - Cardiac, donor4	11452-119A3	132.15	28.80	3.64	0.30
Fibroblast - Cardiac, donor5	11456-119A7	242.77	49.11	4.19	0.89
Fibroblast - Cardiac, donor6	11460-119B2	233.76	50.78	8.94	0.91
Fibroblast - Choroid Plexus, donor1	11492-119E7	160.52	48.64	2.01	1.61
Fibroblast - Choroid Plexus, donor2	11572-120E6	272.66	32.79	8.63	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	219.72	83.49	11.72	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	102.17	42.44	2.54	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	305.12	29.17	2.04	0.51
Fibroblast - Dermal, donor1	11269-116G9	304.51	54.23	6.10	1.17
Fibroblast - Dermal, donor2	11346-117G5	375.46	76.41	16.51	0.94
Fibroblast - Dermal, donor3	11418-118F5	326.88	52.34	7.13	0.73
Fibroblast - Dermal, donor4	11450-119A1	231.97	89.42	7.69	0.57
Fibroblast - Dermal, donor5	11454-119A5	259.06	103.10	9.42	0.52
Fibroblast - Dermal, donor6	11458-119A9	263.61	114.02	11.04	0.65
Fibroblast - Gingival, donor1	11237-116D4	225.72	51.22	7.29	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	200.95	46.11	8.65	0.26
Fibroblast - Gingival, donor2	11318-117D4	311.27	72.74	16.08	0.79
Fibroblast - Gingival, donor3	11394-118C8	172.10	34.81	2.51	0.97
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	137.13	39.48	3.12	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	191.18	25.55	6.52	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	182.40	53.94	10.76	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	172.55	44.63	10.28	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	19.06	19.76	1.06	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	187.49	48.55	10.38	1.32
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	188.71	51.00	12.14	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	219.61	58.03	24.90	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	174.33	28.47	3.23	0.15
Fibroblast - Lung, donor1	11270-116H1	214.78	35.34	4.08	0.00
Fibroblast - Lung, donor2	11347-117G6	159.66	47.75	7.46	1.49
Fibroblast - Lung, donor3	11419-118F6	159.54	47.27	6.33	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	66.64	37.49	2.50	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	145.46	41.96	2.80	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	31.35	7.28	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	133.56	53.18	5.68	0.81
Fibroblast - Mammary, donor2	11620-122A9	79.88	7.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	166.78	23.83	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	277.19	77.98	10.09	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	205.83	66.13	11.07	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	94.86	37.02	3.67	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	196.92	50.37	7.25	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	361.25	66.15	14.58	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	200.75	24.35	5.22	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	286.28	75.83	24.87	1.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	100.78	35.36	3.66	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	140.32	28.06	3.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	300.87	47.84	7.51	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	118.27	36.71	10.91	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	209.59	44.23	3.55	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	209.30	41.78	6.50	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	128.16	45.43	9.63	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	203.49	49.01	4.97	0.97
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	77.44	30.88	5.31	0.00
Fibroblast - skin normal, donor1	11553-120C5	200.83	40.20	3.61	1.80
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	150.78	46.12	17.44	0.40
Fibroblast - skin normal, donor2	11561-120D4	205.04	53.55	5.22	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	88.25	33.25	6.04	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	230.31	34.38	5.22	0.75
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	276.60	44.45	3.93	1.71
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	89.66	34.81	5.91	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	214.22	60.08	7.46	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	172.56	57.35	8.60	1.52
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	213.27	50.65	6.27	1.57
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	2060.86	686.95	221.60	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	367.79	52.29	12.20	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	216.00	53.57	4.16	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	162.13	59.07	7.29	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	186.01	52.38	8.43	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	573.40	180.67	37.51	9.95
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	652.11	222.05	55.51	7.66
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	471.54	214.23	23.96	2.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	403.16	129.05	7.72	2.48
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	237.23	113.93	6.62	2.05
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	336.23	144.44	19.02	2.77
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	348.39	114.19	8.46	2.91
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	232.22	133.39	4.24	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	378.10	171.58	18.57	3.98
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	330.69	106.84	11.45	5.09
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	254.29	77.21	9.61	2.96
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	320.20	95.90	24.18	6.72
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	200.96	69.50	7.81	1.98
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	232.56	70.46	5.54	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	280.56	73.80	17.69	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	218.37	54.99	11.18	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	204.91	57.05	4.61	1.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	206.12	45.25	4.37	2.19
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	301.39	63.23	8.86	4.14
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	202.35	68.83	4.29	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	198.62	52.73	6.03	1.79
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	223.01	55.05	7.26	4.44
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	200.35	78.88	5.94	2.37
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	220.35	62.43	7.71	1.15
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	189.07	61.71	4.99	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	152.50	55.67	4.95	2.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	169.74	64.29	4.09	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	215.40	69.05	8.57	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	190.91	62.28	7.15	2.86
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	252.31	66.02	7.22	2.89
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	172.36	57.76	3.23	1.50
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	187.61	51.70	6.50	1.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	198.83	45.63	2.87	1.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	203.55	64.08	3.07	1.72
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	183.00	53.17	6.16	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	276.78	54.52	6.74	2.89
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	148.10	47.76	2.84	0.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	164.34	40.65	5.54	1.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	229.89	59.60	5.47	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	167.05	58.86	3.97	1.25
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	160.49	40.62	5.05	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	195.82	45.17	5.05	2.24
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	107.86	43.52	2.69	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	141.19	44.12	7.49	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	127.30	39.63	6.89	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	124.74	53.89	4.40	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	121.98	37.68	2.98	2.17
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	156.51	37.79	5.35	1.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	171.06	35.97	6.80	1.75
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	84.30	21.82	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	158.82	40.63	6.46	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	167.86	38.33	5.45	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	56.68	15.76	1.02	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	281.47	110.48	12.14	4.98
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	303.07	87.52	11.25	3.85
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	301.56	133.59	10.64	4.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	517.90	180.25	39.12	7.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	551.55	168.97	48.60	5.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	429.38	173.87	25.83	6.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	621.17	217.78	47.02	9.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	582.53	187.22	41.78	7.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	497.39	216.60	57.76	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	417.32	132.15	19.13	8.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	601.81	159.48	41.01	8.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	464.92	170.90	24.30	5.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	456.52	146.62	13.33	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	563.77	137.03	25.17	10.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	467.71	134.99	17.98	6.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	323.79	106.53	14.26	6.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	570.62	139.63	22.27	9.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	551.61	139.26	24.46	5.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	749.64	231.78	33.41	16.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	700.98	138.59	29.78	10.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	440.72	94.42	15.39	4.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	487.91	123.67	27.11	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	630.42	153.26	36.45	5.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	529.99	130.71	33.14	7.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	642.76	110.64	5.27	21.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	603.53	108.79	21.53	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	541.11	102.68	14.99	7.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	598.61	106.35	6.02	6.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	714.29	108.26	10.40	8.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	443.33	118.79	23.62	6.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	419.93	67.09	12.42	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	794.12	106.17	11.32	8.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	547.37	85.09	12.67	5.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	539.20	125.64	12.21	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	889.81	125.24	20.74	14.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	679.35	120.38	10.85	7.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	794.44	140.47	18.89	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	855.33	123.69	16.34	11.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	547.29	65.39	7.90	6.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	510.31	77.14	19.50	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	433.36	83.57	19.70	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	560.46	96.56	14.56	6.79
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	216.85	30.82	6.85	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	106.86	32.02	5.82	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	214.77	57.35	14.62	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	251.83	29.81	5.07	3.81
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	457.01	37.60	5.85	2.51
Hep-2 cells mock treated, biol_rep1	11898-125E8	283.37	66.72	26.81	1.28
Hep-2 cells mock treated, biol_rep2	11899-125E9	213.03	61.44	17.72	1.35
Hep-2 cells mock treated, biol_rep3	11900-125F1	222.73	65.98	18.43	1.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	279.83	64.82	25.80	1.20
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	208.25	52.01	18.27	1.93
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	223.25	59.85	18.08	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	301.38	58.53	22.04	1.99
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	235.37	46.66	21.62	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	240.28	45.81	23.07	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	146.06	38.05	1.68	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	87.86	17.31	2.16	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	187.71	31.73	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	168.95	32.10	2.12	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	134.40	23.97	3.63	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	254.39	58.22	20.11	3.67
Hepatocyte, donor1	11523-119I2	208.22	119.85	0.00	0.00
Hepatocyte, donor2	11603-120I1	176.68	37.71	1.08	1.08
Hepatocyte, donor3	11684-122I1	248.48	53.38	7.98	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	401.40	74.41	19.58	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	225.29	64.32	13.81	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	183.99	53.51	12.49	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	175.11	85.97	25.47	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	120.16	46.73	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	162.50	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	204.89	58.14	11.08	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	130.14	42.55	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	178.02	83.08	23.74	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	146.09	82.01	17.94	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	91.42	41.14	9.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	164.06	77.97	8.12	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	173.40	61.69	13.34	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	101.66	68.98	7.26	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	152.20	84.70	7.94	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	213.97	85.37	14.41	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	141.43	36.67	15.71	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	211.63	88.81	12.60	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	241.27	54.13	15.47	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	131.71	58.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	177.01	82.69	8.40	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	186.75	96.60	19.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	119.48	47.79	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	202.90	91.27	13.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	137.28	45.76	8.82	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	100.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	187.26	90.01	12.86	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	171.73	63.71	12.93	2.77
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	120.65	90.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	225.16	83.08	15.11	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	198.63	69.84	11.79	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	191.65	58.97	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	158.19	104.38	12.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	167.70	88.93	22.87	3.81
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	147.87	98.58	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	156.87	90.55	14.67	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	178.62	65.62	10.94	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	158.04	94.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	134.24	74.26	13.57	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	172.55	109.50	29.86	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	145.94	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	196.92	88.28	16.05	1.85
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	200.19	68.48	8.78	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	182.30	88.01	9.43	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	174.54	67.45	17.38	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	157.13	53.11	13.28	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	171.83	74.57	9.73	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	156.08	65.39	6.10	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	191.23	56.24	13.50	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	104.54	69.69	3.48	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	176.02	62.94	7.47	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	164.87	70.66	6.93	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	119.68	85.49	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	148.19	60.75	23.01	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	223.87	42.35	15.13	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	99.34	55.88	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	183.98	51.81	6.34	1.06
Keratinocyte - epidermal, donor1	11272-116H3	134.15	35.17	4.90	0.08
Keratinocyte - epidermal, donor2	11349-117G8	251.82	46.27	5.27	0.59
Keratinocyte - epidermal, donor3	11421-118F8	249.61	66.45	11.07	1.04
Keratinocyte - oral, donor1	11251-116E9	371.43	52.22	6.92	1.36
Keratocytes, donor1	11527-119I6	183.95	29.57	4.13	1.38
Keratocytes, donor2	11607-120I5	144.13	33.98	3.52	1.17
Keratocytes, donor3	11688-122I5	186.53	15.61	1.58	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	41.76	17.58	4.40	0.00
Lens Epithelial Cells, donor1	11529-119I8	187.70	48.54	7.55	3.24
Lens Epithelial Cells, donor2	11609-120I7	179.23	41.63	2.42	0.12
Lens Epithelial Cells, donor3	11690-122I7	264.99	33.60	6.66	1.31
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	204.55	42.09	3.68	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	213.49	30.14	5.86	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	224.94	42.34	4.25	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	251.65	62.91	4.84	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	201.39	33.72	5.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	237.30	34.28	4.10	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	169.49	36.11	4.10	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	229.31	34.64	4.05	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	207.33	35.33	3.80	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	230.99	39.95	7.12	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	252.05	35.29	4.46	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	216.44	36.10	5.37	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	178.74	34.84	5.92	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	210.14	26.71	4.29	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	206.85	37.63	4.81	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	194.94	33.26	5.24	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	207.31	24.32	3.12	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	198.54	35.32	4.39	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	169.49	29.62	5.92	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	208.82	32.80	3.22	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	231.25	32.36	4.98	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	201.74	37.83	3.39	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	232.67	35.01	5.66	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	231.61	42.99	5.75	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	173.67	34.73	3.63	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	215.04	31.83	4.82	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	235.78	43.91	5.11	1.20
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	222.87	44.71	4.13	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	213.55	31.61	5.83	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	206.33	32.76	4.45	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	168.15	33.44	5.33	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	161.43	21.83	1.65	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	207.64	34.19	4.21	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	208.06	48.87	5.55	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	199.89	33.85	3.95	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	245.56	36.44	3.57	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	182.69	33.77	3.86	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	209.99	32.56	4.87	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	282.31	45.91	5.04	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	213.34	50.13	5.33	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	192.94	25.69	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	194.20	28.79	2.96	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	252.11	49.06	2.86	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	193.72	32.67	2.61	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	196.58	36.49	5.65	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	185.50	34.40	3.59	0.74
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	164.18	20.75	3.07	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	208.25	37.29	2.39	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	303.65	33.99	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	299.95	29.92	4.60	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	231.57	26.72	3.71	2.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	244.99	32.16	6.35	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	289.77	42.20	6.33	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	231.62	30.82	6.54	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	259.18	29.37	7.73	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	265.25	26.17	5.95	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	279.35	28.50	6.79	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	355.10	42.46	8.14	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	326.83	36.46	8.55	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	234.26	29.67	6.64	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	300.92	35.95	4.62	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	310.51	33.87	7.76	2.12
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	200.56	35.98	6.66	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	290.86	34.13	6.11	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	321.77	37.62	6.94	2.40
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	369.58	41.57	10.20	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	306.78	34.97	6.75	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	301.71	36.69	8.15	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	322.57	38.94	10.62	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	357.89	42.60	10.93	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	286.43	30.91	5.15	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	336.75	36.87	11.61	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	366.49	40.06	6.28	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	280.50	33.20	9.96	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	262.99	26.51	8.13	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	322.68	34.67	6.64	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	287.82	37.99	5.76	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	299.71	31.47	8.83	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	296.65	31.70	7.36	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	317.52	32.00	7.38	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	265.26	29.37	4.97	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	341.12	36.63	8.62	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	253.20	35.10	10.46	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	238.56	28.98	5.57	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	318.32	28.43	11.63	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	316.83	34.25	5.99	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	309.19	27.65	10.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	303.46	25.94	11.46	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	254.54	33.42	6.40	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	326.19	27.50	9.97	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	310.24	28.45	8.05	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	277.42	30.97	6.06	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	337.07	31.48	10.74	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	347.72	38.38	6.98	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	210.49	35.96	6.35	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	305.32	30.41	7.60	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	236.23	30.53	5.81	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	281.31	34.49	8.43	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	315.20	36.01	10.36	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	246.52	34.81	8.47	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	273.03	40.23	9.55	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	280.74	34.70	9.01	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	213.42	49.91	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	301.94	47.21	12.02	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	263.55	28.54	12.12	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	286.98	32.33	11.22	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	318.10	36.84	16.09	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	266.92	31.94	10.94	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	303.03	36.34	7.27	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	302.97	33.12	15.90	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	376.07	38.57	13.11	2.70
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	322.04	42.03	10.13	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	291.26	38.45	11.05	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	302.14	34.98	11.93	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	310.49	36.46	14.58	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	300.20	38.74	11.76	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	359.09	31.16	16.34	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	330.51	42.86	6.71	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	229.16	25.40	6.05	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	331.16	36.44	8.87	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	260.15	35.18	4.80	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	297.10	28.73	7.47	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	283.34	27.25	10.80	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	263.84	29.00	9.90	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	272.96	35.18	9.08	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	298.29	32.03	7.07	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	256.84	38.37	12.53	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	304.81	35.49	4.59	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	313.63	33.92	6.97	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	319.80	32.11	8.03	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	285.50	42.24	6.95	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	300.65	26.27	6.06	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	242.29	32.12	3.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	231.17	33.79	2.67	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	355.03	31.34	7.98	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	245.41	26.84	10.74	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	342.53	37.21	14.23	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	294.89	32.07	9.80	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	279.97	37.17	11.70	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	342.16	36.47	13.93	3.98
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	349.21	35.34	12.47	0.00
Macrophage - monocyte derived, donor1	11232-116C8	108.03	21.42	0.91	0.91
Macrophage - monocyte derived, donor2	11313-117C8	79.64	32.30	1.84	0.00
Macrophage - monocyte derived, donor3	11389-118C3	119.55	22.94	1.97	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	388.18	130.10	10.62	0.00
Mallassez-derived cells, donor2	11929-125I3	172.40	49.91	5.86	0.32
Mallassez-derived cells, donor3	11930-125I4	242.67	84.64	11.67	0.83
Mammary Epithelial Cell, donor1	11273-116H4	364.40	65.07	9.07	1.10
Mammary Epithelial Cell, donor2	11350-117G9	285.50	49.80	11.00	1.74
Mammary Epithelial Cell, donor3	11422-118F9	226.23	41.40	5.49	0.25
Mast cell - stimulated, donor1	11487-119E2	124.06	20.34	6.78	0.00
Mast cell, donor1	11563-120D6	177.24	18.71	1.19	0.54
Mast cell, donor2	11565-120D8	233.88	10.70	2.67	0.89
Mast cell, donor3	11566-120D9	285.23	12.16	1.35	0.90
Mast cell, donor4	11567-120E1	252.28	11.70	2.13	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	151.48	16.19	2.22	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	244.56	22.76	13.42	0.00
Mast cell, expanded, donor5	11939-126A4	182.41	16.98	2.06	0.34
Mast cell, expanded, donor8	11941-126A6	208.04	10.71	2.68	0.33
Melanocyte - dark, donor1	11502-119F8	267.55	42.39	5.57	0.90
Melanocyte - dark, donor2	11582-120F7	254.72	43.95	4.85	1.38
Melanocyte - dark, donor3	11663-122F7	123.95	48.25	8.04	0.51
Melanocyte - light, donor1	11274-116H5	54.07	12.93	0.94	0.00
Melanocyte - light, donor2	11351-117H1	56.64	15.70	0.68	0.00
Melanocyte - light, donor3	11423-118G1	100.60	13.88	4.34	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	168.68	61.33	10.72	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	174.27	35.77	10.76	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	113.84	23.84	4.82	1.61
Meningeal Cells, donor1	11493-119E8	115.62	54.59	3.23	0.50
Meningeal Cells, donor2	11573-120E7	238.56	71.30	5.72	2.64
Meningeal Cells, donor3	11654-122E7	175.88	65.04	15.49	1.14
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	294.85	85.26	12.83	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	305.82	28.78	11.67	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	22.34	14.46	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	39.24	17.01	2.62	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	340.15	61.00	23.68	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	133.41	33.88	3.39	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	155.32	43.73	7.54	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	132.73	63.95	6.81	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	197.99	62.10	17.53	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	117.03	50.13	7.57	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	250.01	41.00	2.63	2.08
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	52.04	12.64	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	263.41	32.24	4.87	1.58
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	119.59	14.24	1.78	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	60.72	14.01	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	163.30	55.07	8.33	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	382.80	89.32	25.52	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	335.87	39.72	5.63	2.19
Mesenchymal stem cells - umbilical, donor0	11214-116A8	325.11	81.28	22.50	1.45
Mesothelial Cells, donor1	11247-116E5	129.14	48.26	3.45	0.00
Mesothelial Cells, donor2	12156-128G5	181.17	66.06	10.01	0.00
Mesothelial Cells, donor3	11402-118D7	117.14	30.06	3.18	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	103.97	12.15	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	180.52	28.57	2.96	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	100.41	23.56	1.47	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	171.09	17.05	1.86	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	80.48	21.16	1.04	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	34.74	4.63	4.63	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	165.67	21.02	1.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	88.44	13.03	2.33	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	140.22	19.31	1.22	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	76.82	18.61	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	164.60	18.58	0.88	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	111.32	23.18	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	22.37	3.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	162.56	19.31	1.49	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	38.67	4.60	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	102.53	11.92	0.89	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	28.50	13.41	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	161.58	21.33	2.51	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	59.89	15.21	1.43	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	35.94	6.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	129.86	18.42	2.30	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	70.67	16.41	0.84	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	105.99	11.82	2.04	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	147.17	17.38	2.79	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	59.80	14.89	1.33	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	98.34	14.67	1.10	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	49.68	7.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	31.48	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	118.23	16.31	1.90	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	53.82	14.12	1.76	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	28.35	6.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	158.10	14.90	2.40	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	66.84	16.81	2.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	32.91	6.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	138.66	15.02	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	40.77	6.12	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	104.23	16.64	3.94	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	28.69	6.62	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	26.26	7.04	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	108.09	25.04	2.23	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	46.63	9.05	1.39	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	30.94	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	76.58	19.83	1.37	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	28.01	5.25	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	31.60	3.55	0.71	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	83.32	26.09	2.52	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	40.32	7.48	2.08	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	14.57	6.99	2.33	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	49.47	16.89	2.41	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	60.52	17.95	2.50	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	50.80	19.39	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	44.96	18.21	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	50.16	13.40	0.83	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	55.72	18.40	1.55	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	38.18	15.44	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	17.79	3.18	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	36.30	12.81	1.33	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	33.23	14.67	0.90	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	32.35	9.18	0.85	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	46.50	19.43	1.91	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	34.94	18.35	0.88	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	25.03	4.55	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	46.03	19.89	1.70	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	31.71	16.47	1.23	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.08	7.17	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	38.52	15.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	28.83	17.88	1.44	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	36.27	9.48	1.24	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	30.67	11.32	1.19	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	271.22	60.27	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	249.52	19.60	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	153.11	29.90	0.99	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	207.23	27.35	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	179.30	25.50	2.17	0.99
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	151.81	11.18	1.86	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	179.13	34.17	1.88	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	128.11	26.10	0.27	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	150.54	28.50	1.70	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	139.24	15.47	2.21	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	124.95	20.15	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	129.11	37.33	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	288.06	52.91	2.67	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	193.20	11.59	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	170.68	21.21	1.01	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	207.87	25.72	1.26	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	478.04	53.12	5.45	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	638.97	48.96	1.91	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	647.87	72.08	3.24	3.24
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	317.19	46.82	3.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	331.19	5.71	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	525.25	71.77	9.79	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	109.31	28.51	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	225.88	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	188.94	53.86	12.50	2.37
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	172.46	47.56	3.14	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	155.52	18.02	4.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	89.73	18.78	3.76	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	291.30	47.54	13.88	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	188.31	59.05	12.77	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	97.91	12.92	1.36	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	178.25	42.27	12.86	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	135.19	19.67	4.60	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	160.15	31.61	2.79	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	228.88	23.51	5.67	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	185.85	28.59	4.63	1.26
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	623.54	89.08	22.27	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	198.54	19.36	2.98	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	184.06	21.11	2.71	1.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	183.39	23.80	2.04	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	117.09	14.86	3.10	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	181.71	20.59	3.65	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	180.35	18.57	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	139.27	8.40	0.60	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	190.34	27.24	1.64	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	109.45	17.56	1.30	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	189.79	22.58	4.41	1.76
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	209.56	15.47	2.81	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	161.36	13.79	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	210.80	26.35	3.86	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	199.35	36.21	4.14	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	262.96	40.46	5.06	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	167.31	18.94	4.68	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	166.82	15.24	3.39	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	171.13	16.14	1.90	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	293.61	29.19	0.86	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	704.17	108.33	45.14	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	248.58	24.99	1.67	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	152.84	12.62	5.41	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	186.50	27.38	5.56	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	193.16	17.64	4.64	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	265.24	27.62	4.54	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	145.35	21.83	3.26	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	167.78	18.74	1.31	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	218.00	22.16	5.43	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	217.83	24.69	7.06	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	250.65	17.29	3.32	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	262.41	15.87	3.47	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	148.54	15.31	3.06	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	197.80	35.69	3.02	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	166.43	23.87	4.64	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	250.05	17.62	4.74	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	260.59	35.77	10.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	251.80	25.00	3.05	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	146.67	13.85	2.20	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	210.95	16.95	2.72	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	204.11	12.66	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	179.12	19.27	4.53	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	384.40	55.64	5.06	0.00
Myoblast, donor1	11241-116D8	284.11	64.72	24.22	0.50
Myoblast, donor2	11322-117D8	231.68	44.69	10.93	0.38
Myoblast, donor3	11398-118D3	165.30	47.93	8.07	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	461.00	35.32	10.65	2.19
Natural Killer Cells, donor1	11230-116C6	455.43	18.14	6.15	0.92
Natural Killer Cells, donor2	11311-117C6	550.64	13.57	4.82	1.81
Natural Killer Cells, donor3	11387-118C1	488.85	13.44	6.26	2.02
Neural stem cells, donor1	11275-116H6	81.30	59.89	8.35	0.36
Neural stem cells, donor2	11352-117H2	105.91	48.14	1.93	1.93
Neurons, donor1	11494-119E9	236.68	127.44	17.07	1.14
Neurons, donor2	11574-120E8	178.33	48.44	6.83	1.54
Neurons, donor3	11655-122E8	238.43	113.46	18.91	1.64
Neutrophils, donor1	11233-116C9	12.06	4.64	0.00	0.00
Neutrophils, donor2	11314-117C9	31.89	5.80	0.00	0.00
Neutrophils, donor3	11390-118C4	34.21	5.50	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	303.01	28.02	4.04	1.31
Nucleus Pulposus Cell, donor2	11409-118E5	229.88	28.00	2.93	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	355.98	40.71	2.81	1.20
Olfactory epithelial cells, donor1	11933-125I7	226.30	31.11	3.17	0.83
Olfactory epithelial cells, donor2	11934-125I8	297.89	41.25	10.86	0.72
Olfactory epithelial cells, donor3	11935-125I9	277.63	36.09	4.99	1.48
Olfactory epithelial cells, donor4	11936-126A1	312.94	31.65	7.69	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	184.16	65.00	9.03	0.60
Osteoblast - differentiated, donor1	11276-116H7	436.87	43.39	6.59	2.55
Osteoblast - differentiated, donor2	11353-117H3	267.49	24.01	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	284.91	32.90	2.48	1.24
Osteoblast, donor1	11277-116H8	600.58	85.02	23.65	2.35
Osteoblast, donor2	11354-117H4	144.68	61.80	9.83	0.70
Osteoblast, donor3	11426-118G4	333.07	64.16	16.88	1.60
Pancreatic stromal cells, donor1	11249-116E7	233.84	44.98	7.92	0.76
Pericytes, donor1	11491-119E6	35.61	10.68	0.11	0.00
Pericytes, donor2	11571-120E5	96.43	18.56	1.36	1.58
Pericytes, donor3	11652-122E5	195.31	44.15	7.93	1.02
Perineurial Cells, donor1	11499-119F5	241.53	55.27	6.33	1.58
Perineurial Cells, donor2	11579-120F4	229.84	42.88	4.51	1.47
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	388.22	10.52	2.55	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	376.84	11.26	4.16	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	321.34	10.74	5.82	0.52
Placental Epithelial Cells, donor1	11278-116H9	116.23	51.66	4.30	0.00
Placental Epithelial Cells, donor2	11355-117H5	140.83	25.50	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	171.59	29.45	3.34	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	102.85	33.23	2.85	0.63
Preadipocyte - breast, donor1	11467-119B9	184.02	31.70	1.13	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	55.21	27.93	7.05	0.26
Preadipocyte - breast, donor2	11328-117E5	294.04	43.23	4.73	0.90
Preadipocyte - omental, donor1	11468-119C1	165.59	38.25	3.84	0.32
Preadipocyte - omental, donor2	11329-117E6	117.41	35.35	6.11	0.44
Preadipocyte - omental, donor3	11403-118D8	139.95	52.43	8.45	0.43
Preadipocyte - perirenal, donor1	11469-119C2	270.67	48.23	3.94	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	317.87	40.23	23.34	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	280.14	83.58	30.10	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	303.45	66.24	18.05	2.04
Preadipocyte - visceral, donor1	11280-116I2	207.53	62.32	13.04	0.19
Preadipocyte - visceral, donor2	11357-117H7	185.45	56.14	12.42	0.00
Preadipocyte - visceral, donor3	11429-118G7	273.87	78.26	15.67	1.78
Prostate Epithelial Cells (polarized), donor1	11253-116F2	312.11	84.48	15.99	1.06
Prostate Epithelial Cells, donor2	11331-117E8	162.90	53.76	5.55	0.14
Prostate Epithelial Cells, donor3	11404-118D9	220.15	21.13	2.08	0.67
Prostate Stromal Cells, donor1	11254-116F3	239.87	62.19	24.83	1.25
Prostate Stromal Cells, donor2	11332-117E9	273.79	62.75	28.87	0.36
Prostate Stromal Cells, donor3	11405-118E1	236.08	41.71	7.09	1.04
Renal Cortical Epithelial Cells, donor1	11516-119H4	95.26	25.91	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	176.12	33.62	3.26	0.14
Renal Epithelial Cells, donor1	11517-119H5	31.45	21.81	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	89.63	28.45	2.85	0.00
Renal Epithelial Cells, donor3	11678-122H4	160.70	40.23	4.45	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	88.51	18.38	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	190.69	54.98	4.85	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	257.53	53.73	19.31	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	18.63	6.65	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	118.19	24.87	4.40	0.66
Renal Mesangial Cells, donor2	11598-120H5	171.79	43.26	3.13	0.63
Renal Mesangial Cells, donor3	11679-122H5	58.26	18.86	1.11	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	157.56	74.89	3.49	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	170.36	44.28	4.64	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	141.36	49.56	3.47	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	250.73	74.15	4.93	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	209.49	43.49	2.56	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	91.59	27.79	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	385.64	51.94	2.26	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	168.65	39.42	1.74	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	304.65	44.67	26.80	8.04
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	525.60	90.81	46.78	9.36
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	330.05	52.78	54.53	6.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	199.72	46.16	16.12	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	251.14	60.38	29.99	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	296.36	71.50	30.67	1.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	356.25	81.00	32.38	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	273.76	65.73	34.03	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	379.29	79.74	49.46	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	241.78	46.41	18.76	2.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	279.10	53.40	40.54	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	290.11	62.90	27.95	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	260.09	57.10	15.35	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	300.05	71.26	38.63	2.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	332.79	88.29	36.51	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	268.79	45.31	22.94	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	258.62	58.69	32.05	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	218.16	64.45	21.23	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	227.86	42.20	15.79	1.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	276.16	72.13	36.21	3.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	312.41	74.66	40.48	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	236.97	45.49	17.19	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	257.32	56.62	37.84	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	278.22	76.90	32.30	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	245.60	48.32	24.61	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	261.21	66.34	30.78	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	321.43	78.17	33.98	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	277.15	58.26	16.75	2.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	285.91	75.20	42.06	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	374.15	79.98	45.83	2.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	272.67	63.04	18.87	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	296.64	70.57	35.17	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	306.43	83.34	33.00	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	253.02	63.12	18.17	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	260.72	60.11	35.59	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	332.96	77.50	41.64	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	267.19	55.71	20.12	3.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	234.01	53.77	32.23	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	363.96	81.26	59.43	2.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	245.93	39.54	14.32	3.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	264.55	73.24	27.52	2.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	290.81	47.98	33.85	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	288.70	51.02	9.96	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	295.48	49.76	20.95	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	325.09	44.74	25.19	5.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	241.46	45.58	9.23	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	422.03	58.34	21.66	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	376.86	44.73	18.13	4.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	244.65	40.02	14.44	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	226.48	55.60	17.90	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	434.42	60.23	27.38	6.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	287.53	41.59	14.17	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	237.50	47.95	18.77	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	229.15	45.53	19.47	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	218.56	35.54	7.20	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	303.09	42.90	24.33	2.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	228.37	33.65	19.23	1.20
Schwann Cells, donor1	11498-119F4	121.31	34.61	1.88	0.00
Schwann Cells, donor2	11578-120F3	221.16	64.65	10.21	3.40
Schwann Cells, donor3	11659-122F3	144.59	53.02	6.79	0.66
Sebocyte, donor1	11220-116B5	196.65	50.39	8.76	0.55
Sebocyte, donor2	11301-117B5	306.52	64.34	17.00	0.46
Sebocyte, donor3	11378-118B1	278.05	37.72	8.04	0.82
Sertoli Cells, donor1	11255-116F4	240.21	51.35	6.63	3.31
Sertoli Cells, donor2	11333-117F1	319.15	33.89	5.65	5.65
Skeletal Muscle Cells, donor1	11281-116I3	275.81	39.77	4.49	0.88
Skeletal Muscle Cells, donor2	11358-117H8	291.31	29.64	1.45	3.61
Skeletal Muscle Cells, donor3	11430-118G8	308.50	62.70	10.87	0.84
Skeletal Muscle Cells, donor4	11451-119A2	318.74	109.97	12.72	1.26
Skeletal Muscle Cells, donor5	11455-119A6	326.87	97.21	13.08	1.34
Skeletal Muscle Cells, donor6	11459-119B1	329.66	122.35	16.93	0.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	347.78	63.38	6.55	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	283.38	56.22	6.14	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	265.29	93.85	14.68	0.89
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	302.97	44.91	7.25	1.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	430.64	61.52	10.86	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	442.66	48.57	6.74	2.75
Skin - palm, donor1	10286-104F7	236.38	37.61	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	135.36	28.83	3.89	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	92.42	72.79	9.00	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	152.03	28.43	3.12	1.04
Small Airway Epithelial Cells, donor1	11256-116F5	266.76	44.34	4.17	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	237.43	34.04	5.77	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	131.94	65.76	12.69	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	197.34	20.31	2.62	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	489.41	49.99	4.32	2.78
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	132.95	36.46	8.89	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	415.01	59.37	8.23	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	91.05	15.91	3.54	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	380.79	56.70	14.18	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	401.73	78.03	12.36	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	337.25	41.03	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	445.68	54.56	10.65	1.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	345.78	54.97	17.51	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	600.46	100.76	25.99	4.23
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	248.75	64.14	6.51	1.63
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	180.74	42.53	5.61	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	205.00	42.57	7.40	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	105.58	21.31	2.93	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	241.11	22.53	3.96	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	299.03	40.92	9.09	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	91.81	30.60	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	352.38	52.45	7.15	2.86
Smooth Muscle Cells - Colonic, donor1	11239-116D6	255.87	44.98	6.34	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	274.64	51.44	7.53	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	262.71	57.94	11.23	0.84
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	416.09	56.92	19.03	0.93
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	425.76	66.83	30.18	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	330.24	53.79	11.66	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	90.13	20.83	3.07	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	301.47	27.33	2.83	1.33
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	146.73	47.60	7.25	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	157.47	36.86	8.19	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	483.05	60.38	11.47	3.02
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	278.17	98.29	23.58	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	170.04	43.41	4.79	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	275.98	53.09	9.02	1.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	204.45	43.12	3.30	1.27
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	254.05	58.50	8.29	0.90
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	275.31	32.26	3.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	208.05	33.60	3.88	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	222.30	53.95	9.30	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	189.84	53.01	10.60	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	284.56	40.43	11.60	2.19
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	130.98	21.53	0.59	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	261.17	69.64	12.25	0.92
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	312.06	26.63	2.34	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	452.62	56.13	19.72	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	467.59	56.86	27.54	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	459.93	65.25	12.60	2.82
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	290.81	62.47	8.52	1.40
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	379.81	45.50	7.37	1.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	46.67	7.14	0.95	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	485.41	59.21	15.41	1.47
Smooth Muscle Cells - Uterine, donor1	11258-116F7	239.73	59.44	6.63	2.21
Smooth Muscle Cells - Uterine, donor3	11466-119B8	264.49	75.49	13.17	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	181.92	30.51	2.72	1.75
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	170.04	40.99	12.16	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	387.94	51.70	12.65	3.72
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	252.61	37.73	7.91	2.87
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	213.49	45.14	14.76	1.70
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	233.56	63.41	18.91	2.76
Smooth muscle cells - airway, control, donor1	11966-126D4	267.41	45.46	7.36	4.32
Smooth muscle cells - airway, control, donor2	11967-126D5	179.69	23.16	3.19	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	360.74	34.28	7.94	2.93
Smooth muscle cells - airway, control, donor4	11969-126D7	272.72	50.42	6.88	3.67
Synoviocyte, donor1	11291-117A4	201.65	44.61	5.72	1.18
Synoviocyte, donor2	11368-117I9	240.88	29.67	5.03	1.01
Synoviocyte, donor3	11440-118H9	340.25	27.93	1.79	1.34
Trabecular Meshwork Cells, donor1	11532-120A2	110.06	36.45	7.50	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	47.57	17.84	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	44.92	17.60	0.93	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	431.90	51.40	10.39	0.93
Tracheal Epithelial Cells, donor2	11369-118A1	283.35	48.32	10.05	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	253.12	40.66	6.30	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	168.17	35.43	1.48	0.12
Urethra, donor2	10319-105A4	169.05	5.40	0.00	0.00
Urothelial Cells, donor1	11520-119H8	116.63	19.13	0.80	1.06
Urothelial Cells, donor2	11600-120H7	161.43	19.23	2.00	0.00
Urothelial Cells, donor3	11681-122H7	97.87	11.00	0.69	0.00
Urothelial cells, donor0	11216-116B1	182.11	29.20	3.12	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	302.53	13.35	1.78	4.45
Whole blood (ribopure), donor090309, donation2	12180-129A2	330.24	15.73	1.43	5.72
Whole blood (ribopure), donor090309, donation3	12181-129A3	304.61	9.58	2.74	3.42
Whole blood (ribopure), donor090325, donation1	12176-128I7	366.03	12.74	3.79	8.95
Whole blood (ribopure), donor090325, donation2	12177-128I8	350.94	13.36	1.16	12.78
Whole blood (ribopure), donor090612, donation1	12182-129A4	236.36	12.49	2.08	6.25
Whole blood (ribopure), donor090612, donation2	12183-129A5	325.82	16.52	0.00	6.42
Whole blood (ribopure), donor090612, donation3	12184-129A6	292.13	13.69	0.91	6.39
Wilms' tumor cell line:G-401	10809-111A8	262.76	56.99	10.12	1.73
Wilms' tumor cell line:HFWT	10597-108E3	346.74	25.52	4.40	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	211.44	66.76	6.70	2.23
achilles tendon, donor2	10292-104G4	132.26	6.20	6.20	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	498.18	140.23	12.49	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	608.76	92.41	10.91	1.63
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	335.59	47.25	6.17	1.31
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	483.55	75.38	34.83	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	365.13	55.65	26.14	1.69
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	889.91	43.57	12.48	3.38
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	656.85	28.31	8.44	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	996.72	43.62	15.42	7.05
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	892.67	38.79	8.98	4.49
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	1139.66	62.13	7.77	2.33
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	500.66	158.06	33.12	4.23
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	1045.34	81.91	19.50	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	796.61	52.75	14.18	2.32
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	611.27	134.37	18.90	2.85
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	481.03	83.58	14.90	2.92
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	356.94	35.32	3.25	3.25
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	316.25	46.47	11.93	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	224.69	36.83	12.58	2.15
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	405.37	55.90	11.95	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	397.62	51.86	6.67	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	486.95	64.27	10.59	1.93
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	273.30	73.73	28.07	1.78
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	381.58	92.73	28.69	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	425.53	137.51	27.87	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	377.41	155.56	26.37	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	571.33	46.23	15.70	4.80
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	494.86	69.36	18.74	3.75
adenocarcinoma cell line:IM95m	10796-110I4	407.18	61.94	5.65	2.12
adipose tissue, adult, pool1	10010-101C1	143.64	20.48	1.71	0.00
adipose, donor1	10184-103D4	483.20	148.36	17.59	7.04
adipose, donor2	10185-103D5	218.57	77.45	2.43	2.03
adipose, donor3	10186-103D6	200.13	107.83	8.17	1.09
adipose, donor4	10187-103D7	239.22	95.34	5.20	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	194.91	47.35	6.31	1.26
adrenal gland, adult, pool1	10081-102A9	192.80	58.20	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	169.16	20.94	3.07	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	320.86	58.24	17.15	1.07
amniotic membrane cells, donor1	12235-129G3	164.61	37.33	2.78	0.23
amniotic membrane cells, donor2	12236-129G4	285.02	55.79	3.72	1.01
amniotic membrane cells, donor3	12237-129G5	207.10	26.81	2.36	0.29
amygdala - adult, donor10196	10167-103B5	78.26	34.39	4.74	1.19
amygdala, adult, donor10252	10151-102I7	92.26	24.33	2.64	0.00
amygdala, newborn, donor10223	10360-105E9	103.29	27.44	3.55	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	255.30	40.11	2.16	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	571.86	88.47	33.53	4.41
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	468.65	48.77	5.34	2.67
aorta, adult, pool1	10052-101G7	150.04	16.48	1.37	0.00
appendix, adult	10189-103D9	397.04	26.00	10.09	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	459.84	70.51	12.04	0.34
artery, adult	10190-103E1	430.70	59.78	4.08	1.36
astrocytoma cell line:TM-31	10425-106D2	173.99	26.80	6.23	1.01
b cell line:RPMI1788	10427-106D4	378.59	31.52	5.06	1.34
basal cell carcinoma cell line:TE 354.T	10702-109G9	306.58	38.57	7.77	1.39
bile duct carcinoma cell line:HuCCT1	10432-106D9	220.49	67.68	6.35	0.79
bile duct carcinoma cell line:TFK-1	10496-107C1	271.65	35.15	3.85	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	756.09	60.40	3.36	2.24
bladder, adult, pool1	10011-101C2	254.22	13.47	2.17	0.22
blood, adult, pool1	10053-101G8	403.06	13.29	0.00	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	186.68	33.40	9.42	1.71
bone marrow, adult	10192-103E3	122.14	47.24	4.72	0.67
brain, adult, donor1	10084-102B3	74.83	44.08	0.00	1.03
brain, adult, pool1	10012-101C3	73.27	27.73	3.01	0.78
brain, fetal, pool1	10085-102B4	277.83	24.04	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	423.20	43.61	6.61	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	206.58	36.57	3.74	0.25
breast, adult, donor1	10080-102A8	226.03	15.78	1.89	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	223.46	85.62	5.34	1.02
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	477.75	85.65	10.20	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	554.37	102.91	5.99	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	267.51	53.74	13.80	2.18
carcinoid cell line:NCI-H1770	10703-109H1	314.54	116.60	13.16	0.47
carcinoid cell line:NCI-H727	10735-110B6	224.01	73.07	6.13	0.98
carcinoid cell line:SK-PN-DW	10719-109I8	556.47	69.08	10.46	3.17
carcinosarcoma cell line:JHUCS-1	10642-109A3	810.51	105.67	10.65	3.46
caudate nucleus - adult, donor10196	10177-103C6	111.68	36.84	2.30	2.30
caudate nucleus, adult, donor10252	10164-103B2	92.87	23.76	7.20	1.17
caudate nucleus, adult, donor10258	10379-105H1	140.60	41.26	6.88	3.06
caudate nucleus, newborn, donor10223	10354-105E3	172.50	33.69	9.52	2.93
cerebellum - adult, donor10196	10173-103C2	113.62	40.79	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	50.82	20.92	1.28	0.21
cerebellum, adult, pool1	10083-102B2	113.83	33.46	2.76	0.69
cerebellum, newborn, donor10223	10357-105E6	110.43	37.36	2.49	1.66
cerebral meninges, adult	10188-103D8	174.48	30.76	4.79	1.01
cerebrospinal fluid, donor2	10294-104G6	475.81	44.58	4.39	0.73
cervical cancer cell line:D98-AH2	10552-107I3	184.04	24.30	8.48	2.44
cervical cancer cell line:ME-180	10553-107I4	409.15	56.34	13.42	1.82
cervix, adult, pool1	10013-101C4	239.27	20.47	2.52	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	11.43	6.69	0.14	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	146.30	15.68	2.61	1.31
choriocarcinoma cell line:BeWo	10423-106C9	563.47	93.33	7.83	0.99
choriocarcinoma cell line:SCH	10785-110H2	395.51	53.47	2.96	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	419.33	76.13	2.37	0.00
chorionic membrane cells, donor1	12238-129G6	180.07	26.50	3.42	0.00
chorionic membrane cells, donor2	12239-129G7	215.47	52.60	11.83	0.89
chorionic membrane cells, donor3	12240-129G8	262.65	29.67	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	528.13	67.66	16.16	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	469.68	47.45	13.25	2.88
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	496.92	51.32	10.98	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	216.74	96.04	11.81	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	233.17	74.01	13.79	2.18
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	222.75	83.28	18.73	2.24
chronic myelogenous leukemia cell line:K562	10454-106G4	433.73	140.16	23.56	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	368.26	58.90	10.95	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	175.78	27.89	6.63	0.46
clear cell carcinoma cell line:TEN	10636-108I6	267.20	73.74	4.86	0.17
colon carcinoma cell line:CACO-2	10513-107D9	348.51	113.12	13.55	1.46
colon carcinoma cell line:COLO-320	10420-106C6	262.64	99.58	3.80	0.38
colon, adult, donor1	10082-102B1	218.97	26.18	3.57	0.00
colon, adult, pool1	10014-101C5	381.06	37.01	2.82	0.24
colon, fetal, donor1	10070-101I7	528.38	24.72	0.00	1.85
common myeloid progenitor CMP, donor1	12130-128D6	137.51	13.75	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	2653.89	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	300.43	51.42	36.97	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	229.72	34.56	38.34	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	262.42	34.27	43.15	1.83
corpus callosum, adult, pool1	10042-101F6	112.00	35.27	0.55	0.11
cruciate ligament, donor2	10295-104G7	132.11	21.88	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	209.47	41.73	2.41	0.00
diencephalon, adult	10193-103E4	111.83	51.12	3.12	2.16
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	678.73	75.54	13.09	2.07
ductal cell carcinoma cell line:KLM-1	10438-106E6	176.43	43.85	2.56	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	398.15	37.31	13.72	1.20
ductus deferens, adult	10196-103E7	157.48	26.41	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	504.08	44.65	4.32	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	393.57	34.58	2.21	3.68
dura mater, adult, donor1	10041-101F5	175.99	24.53	1.24	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	248.94	259.60	20.65	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	160.35	161.06	19.77	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	439.65	26.51	9.87	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	497.35	18.16	4.54	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	447.69	24.70	12.04	0.00
embryonic pancreas cell line:2C6	10603-108E9	421.62	18.39	15.76	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	452.51	55.98	11.40	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	220.93	38.42	3.62	1.27
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	232.21	67.22	6.59	0.64
epidermoid carcinoma cell line:A431	10426-106D3	136.39	35.46	13.23	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	168.39	44.54	10.23	1.10
epididymis, adult	10197-103E8	164.10	45.21	3.56	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	208.10	45.95	4.26	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	196.23	25.95	8.65	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	217.02	39.71	12.97	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	206.68	30.21	11.91	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	197.96	51.09	15.46	0.34
esophagus, adult, pool1	10015-101C6	272.77	25.59	2.65	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	366.69	35.94	5.76	1.75
eye - muscle inferior rectus, donor1	10272-104E2	77.27	16.90	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	92.58	23.15	0.00	0.00
eye - muscle medial, donor2	10299-104H2	44.65	1.49	1.49	0.00
eye - muscle superior, donor2	10297-104G9	66.50	16.05	1.15	1.15
eye - vitreous humor, donor1	10268-104D7	164.69	20.40	2.91	1.46
eye, fetal, donor1	10054-101G9	140.59	34.32	0.25	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	289.53	79.37	11.16	1.03
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	384.38	89.51	28.97	1.66
frontal lobe, adult, pool1	10040-101F4	60.23	36.12	1.60	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	123.40	44.14	6.31	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	131.39	56.42	2.29	0.09
gall bladder, adult	10198-103E9	210.53	34.77	3.38	0.48
gamma delta positive T cells, donor1	11937-126A2	860.58	19.33	4.29	3.76
gamma delta positive T cells, donor2	11938-126A3	527.74	17.93	5.98	2.24
gastric adenocarcinoma cell line:MKN1	10614-108G2	182.91	48.16	8.45	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	801.71	72.14	7.35	2.90
gastric cancer cell line:AZ521	10549-107H9	235.60	105.75	7.71	0.98
gastric cancer cell line:GSS	10560-108A2	218.74	47.59	4.58	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	119.03	60.77	4.34	0.00
giant cell carcinoma cell line:LU65	10487-107B1	329.88	19.62	6.43	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	153.40	72.50	3.36	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	304.79	49.14	12.22	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	121.28	85.18	7.71	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	138.89	83.28	8.43	0.84
glioblastoma cell line:T98G	10485-107A8	110.48	35.65	7.28	0.33
glioma cell line:GI-1	10413-106B8	230.20	18.74	3.51	0.59
globus pallidus - adult, donor10196	10175-103C4	121.73	47.38	4.37	2.92
globus pallidus, adult, donor10252	10161-103A8	142.55	28.56	2.20	0.00
globus pallidus, adult, donor10258	10367-105F7	157.46	41.08	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	136.43	29.31	5.33	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	107.67	22.02	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	1595.54	32.79	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	2451.27	114.98	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	172.80	37.76	8.00	0.64
hIPS +CCl2, biol_rep1	14383-156B9	263.53	146.46	15.15	9.18
hIPS +CCl2, biol_rep2	14384-156C1	238.23	118.89	22.86	11.43
hIPS +CCl2, biol_rep3	14385-156C2	249.91	123.67	20.61	14.17
hIPS, biol_rep1	14380-156B6	143.73	102.05	21.56	21.56
hIPS, biol_rep2	14381-156B7	205.76	127.57	21.26	19.20
hIPS, biol_rep3	14382-156B8	99.31	71.73	5.52	3.31
hairy cell leukemia cell line:Mo	10712-109I1	297.40	40.80	25.57	3.16
heart - mitral valve, adult	10205-103F7	108.23	30.79	2.09	0.00
heart - pulmonic valve, adult	10206-103F8	131.00	32.16	1.31	0.26
heart - tricuspid valve, adult	10207-103F9	239.80	18.32	5.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	81.21	35.30	1.22	0.00
heart, adult, diseased, donor1	10051-101G6	54.93	25.98	1.28	0.00
heart, adult, pool1	10016-101C7	135.92	28.98	1.61	0.23
heart, fetal, pool1	10046-101G1	152.07	29.57	1.23	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	202.08	30.24	5.55	1.54
hepatoblastoma cell line:HuH-6	10633-108I3	379.35	54.70	5.95	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	409.39	137.24	33.37	1.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	449.81	138.12	36.53	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	462.02	142.08	37.19	1.11
hepatoma cell line:Li-7	10484-107A7	86.08	40.70	7.90	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	334.87	97.89	16.48	4.42
hippocampus - adult, donor10196	10169-103B7	76.65	28.39	5.68	0.95
hippocampus, adult, donor10252	10153-102I9	92.66	21.43	3.47	0.61
hippocampus, adult, donor10258	10374-105G5	68.22	28.38	5.48	5.48
hippocampus, newborn, donor10223	10363-105F3	84.24	24.32	3.17	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	598.14	242.31	43.94	12.21
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	382.50	140.59	25.92	3.53
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	375.26	146.75	26.91	4.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	343.96	99.24	5.07	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	509.97	113.10	10.84	5.42
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	413.02	111.23	9.49	7.97
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	242.61	137.51	4.67	2.63
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	278.98	109.87	3.66	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	241.90	123.87	8.34	4.17
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	305.70	145.15	10.18	2.60
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	346.67	142.56	12.38	2.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	326.55	145.43	13.47	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	417.50	125.66	23.63	2.82
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	447.08	168.02	40.29	5.90
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	685.11	218.19	52.37	9.60
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	390.79	77.13	8.02	4.39
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	323.57	71.95	5.23	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	337.34	111.45	12.49	10.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	246.79	67.44	2.83	2.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	268.28	96.85	4.09	4.09
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	238.37	83.63	4.70	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	243.65	101.57	8.82	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	230.80	112.06	7.26	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	189.22	105.52	10.16	2.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	389.44	124.33	30.48	3.88
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	388.27	113.26	21.11	3.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	558.57	182.52	45.73	8.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	365.11	98.58	16.55	8.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	289.82	74.43	10.77	2.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	286.88	80.19	12.71	8.47
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	216.67	80.67	5.17	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	227.14	83.68	6.64	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	177.52	77.47	7.70	2.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	253.60	89.22	11.50	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	256.70	115.10	11.36	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	233.90	100.15	13.11	3.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	377.47	131.38	28.26	3.62
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	451.90	154.20	38.33	9.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	389.76	118.54	28.78	3.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	273.53	66.32	6.72	3.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1633.13	491.24	68.32	48.80
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	449.75	114.18	11.91	6.62
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	235.89	87.57	4.93	4.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	216.77	78.17	7.24	1.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	240.93	90.75	4.27	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	200.49	105.02	8.35	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	174.56	105.50	6.23	1.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	207.43	101.56	12.12	2.16
immature langerhans cells, donor1	11904-125F5	388.64	26.88	10.65	5.09
immature langerhans cells, donor2	11905-125F6	316.85	20.60	3.96	3.96
insula, adult, pool1	10039-101F3	62.17	33.78	2.84	0.76
keratoacanthoma cell line:HKA-1	10791-110H8	240.28	48.77	9.43	2.93
kidney, adult, pool1	10017-101C8	118.95	51.77	1.70	0.20
kidney, fetal, pool1	10045-101F9	75.90	29.57	0.50	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	348.66	36.64	9.52	1.42
large cell lung carcinoma cell line:NCI-H460	10839-111E2	779.41	63.31	8.29	3.46
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	409.94	31.56	6.97	1.47
left atrium, adult, donor1	10079-102A7	145.48	33.78	1.63	0.00
left ventricle, adult, donor1	10078-102A6	144.62	32.36	1.52	0.51
leiomyoblastoma cell line:G-402	10721-110A1	616.99	97.68	33.93	10.40
leiomyoma cell line:10964C	10569-108B2	390.50	52.81	6.11	1.80
leiomyoma cell line:15242A	10570-108B3	275.00	69.57	5.43	0.54
leiomyoma cell line:15425	10571-108B4	329.02	65.80	7.28	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	298.42	57.14	12.70	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	99.33	32.41	6.27	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	414.86	51.36	29.99	4.72
liposarcoma cell line:KMLS-1	10782-110G8	346.01	52.49	6.72	0.94
liposarcoma cell line:SW 872	10726-110A6	119.04	27.05	5.36	0.97
liver, adult, pool1	10018-101C9	205.98	48.78	4.21	0.16
liver, fetal, pool1	10086-102B5	196.61	27.28	1.88	0.94
locus coeruleus - adult, donor10196	10182-103D2	93.04	32.08	2.62	0.00
locus coeruleus, adult, donor10252	10165-103B3	96.70	34.14	2.77	0.18
locus coeruleus, adult, donor10258	10375-105G6	108.62	62.35	2.26	0.28
locus coeruleus, newborn, donor10223	10362-105F2	140.07	53.84	7.57	1.68
lung adenocarcinoma cell line:A549	10499-107C4	305.58	51.62	4.57	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	124.09	32.40	2.07	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	335.08	64.46	5.67	0.66
lung, adult, pool1	10019-101D1	196.21	14.88	1.06	0.12
lung, fetal, donor1	10068-101I5	145.27	41.38	2.28	0.57
lung, right lower lobe, adult, donor1	10075-102A3	196.12	35.28	0.00	1.37
lymph node, adult, donor1	10077-102A5	592.18	24.14	4.73	0.95
lymphangiectasia cell line:DS-1	10727-110A7	696.99	53.70	10.52	3.29
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	507.42	78.63	17.36	1.66
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	163.95	42.47	11.89	0.85
mature adipocyte, donor1	12231-129F8	81.25	37.74	3.55	0.44
mature adipocyte, donor2	12232-129F9	92.35	36.32	2.28	0.62
mature adipocyte, donor3	12233-129G1	89.61	38.88	1.42	0.00
mature adipocyte, donor4	12234-129G2	172.41	47.12	1.58	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	154.87	51.94	4.77	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	40.61	43.99	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	73.38	21.70	2.02	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	75.93	45.43	2.22	2.54
medial frontal gyrus, newborn, donor10223	10352-105E1	170.17	55.44	6.82	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	96.36	33.08	6.08	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	65.15	16.98	2.12	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	63.57	38.53	3.85	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	287.07	86.12	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	102.65	34.10	3.59	0.72
medulla oblongata - adult, donor10196	10174-103C3	186.91	49.97	4.54	0.65
medulla oblongata, adult, donor10252	10155-103A2	109.76	29.72	1.24	0.00
medulla oblongata, adult, pool1	10038-101F2	64.89	40.41	1.14	0.24
medulla oblongata, newborn, donor10223	10361-105F1	99.64	31.94	1.74	0.35
medulloblastoma cell line:D283 Med	10838-111E1	458.54	137.94	8.19	1.77
medulloblastoma cell line:ONS-76	10759-110E3	197.35	52.58	14.67	1.10
melanoma cell line:COLO 679	10514-107E1	114.28	85.96	3.31	0.14
melanoma cell line:G-361	10465-106H6	298.34	45.33	5.97	1.09
meningioma cell line:HKBMM	10691-109F7	250.37	22.25	7.24	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	464.37	131.29	14.98	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	169.27	156.57	6.48	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	394.48	81.17	19.03	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	360.11	35.45	8.91	2.54
mesenchymal precursor cell - adipose, donor3	11749-123G3	286.56	40.17	12.42	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	253.28	24.44	2.95	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	292.32	28.11	7.32	1.54
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	189.48	39.56	13.88	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	279.25	28.83	4.29	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	271.44	28.87	6.33	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	230.13	54.38	11.80	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	257.12	47.80	12.02	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	201.59	41.11	11.67	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	200.25	30.63	5.27	1.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	216.83	46.91	12.04	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	199.33	50.27	10.47	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	261.74	53.90	4.49	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	179.01	40.62	4.67	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	183.11	24.10	1.97	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	121.06	35.34	7.52	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	300.82	75.10	20.56	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	177.08	40.35	8.82	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	217.43	41.84	4.11	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	195.49	30.93	4.05	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	203.17	38.63	11.45	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	271.55	79.57	12.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	254.82	53.43	3.20	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	259.88	37.34	4.60	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	218.04	37.95	5.24	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	212.58	41.28	4.01	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	228.53	40.95	3.77	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	224.73	44.34	6.43	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	212.20	42.44	5.89	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	230.30	41.24	4.63	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	531.34	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	275.73	50.47	4.33	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	204.58	43.28	3.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	207.66	45.67	4.33	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	253.73	51.33	6.60	2.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	209.79	42.29	5.37	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	227.61	39.71	4.09	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	221.65	45.96	4.30	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	380.08	46.48	8.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	382.21	51.65	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	417.35	59.76	9.42	2.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	405.94	58.20	7.27	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	442.46	57.04	7.46	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	366.36	58.06	9.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	389.50	59.47	6.61	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	379.87	48.27	8.39	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	353.67	55.63	8.94	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	333.71	33.37	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	351.04	53.37	6.52	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	414.28	47.52	4.87	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	270.52	0.00	0.00	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	427.53	46.87	10.77	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	417.33	43.46	6.21	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	436.29	34.39	6.45	6.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	311.36	51.89	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	409.82	34.44	6.89	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	458.40	35.86	5.70	2.04
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	512.41	27.81	7.15	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	484.00	18.86	6.48	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	463.50	28.37	4.68	2.49
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	427.74	33.42	5.35	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	376.09	35.48	5.91	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	444.26	43.66	15.41	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	422.68	32.35	7.57	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	250.87	45.03	1.98	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	201.87	51.59	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	248.06	53.43	2.54	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	121.30	82.61	3.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	167.91	74.14	6.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	126.71	58.28	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	71.61	60.69	3.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	140.09	58.75	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	104.61	57.66	4.12	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	300.02	44.45	3.77	1.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	297.56	40.56	6.17	2.27
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	294.38	28.52	3.06	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	225.15	27.85	6.96	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	166.08	39.69	2.36	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	210.59	32.90	7.65	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	111.11	72.65	12.82	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	169.33	48.19	10.28	0.92
mesothelioma cell line:Mero-25	10850-111F4	214.47	36.54	12.26	1.36
mesothelioma cell line:Mero-41	10851-111F5	175.78	52.56	7.58	1.71
mesothelioma cell line:Mero-48a	10852-111F6	138.84	55.36	11.96	1.11
mesothelioma cell line:Mero-82	10853-111F7	158.47	54.66	12.88	1.31
mesothelioma cell line:Mero-83	10854-111F8	187.41	45.28	11.06	0.85
mesothelioma cell line:Mero-84	10855-111F9	257.07	72.29	11.37	1.01
mesothelioma cell line:Mero-95	10856-111G1	142.24	43.48	5.38	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	139.31	76.69	7.95	0.66
mesothelioma cell line:NCI-H226	10846-111E9	158.91	32.22	6.52	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	122.82	35.53	4.95	0.34
mesothelioma cell line:NCI-H28	10845-111E8	310.96	78.88	3.82	0.76
mesothelioma cell line:No36	10857-111G2	127.55	50.56	11.09	0.00
mesothelioma cell line:ONE58	10858-111G3	85.35	51.75	5.15	1.35
migratory langerhans cells, donor1	11901-125F2	109.20	26.29	1.34	0.77
migratory langerhans cells, donor2	11902-125F3	58.74	22.96	0.12	0.24
migratory langerhans cells, donor3	11903-125F4	172.30	32.49	0.90	1.44
mixed mullerian tumor cell line:HTMMT	10689-109F5	97.94	17.96	5.22	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	92.62	34.33	3.81	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	672.87	77.40	16.36	2.53
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	227.59	25.88	18.08	4.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	787.77	94.06	16.08	1.66
myeloma cell line:PCM6	10474-106I6	660.21	34.99	8.30	1.78
myxofibrosarcoma cell line:MFH-ino	10600-108E6	132.40	33.99	15.22	2.54
myxofibrosarcoma cell line:NMFH-1	10684-109E9	220.85	42.95	8.63	2.16
nasal epithelial cells, donor1, tech_rep1	12226-129F3	305.53	35.21	1.67	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	345.35	33.39	3.24	0.44
nasal epithelial cells, donor2	12227-129F4	179.95	40.85	2.76	0.00
neuroblastoma cell line:CHP-134	10508-107D4	873.77	125.84	9.20	2.76
neuroblastoma cell line:NB-1	10539-107G8	223.01	154.91	8.98	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	211.94	94.90	6.75	1.69
neuroblastoma cell line:NH-12	10555-107I6	796.28	131.00	9.50	7.08
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	501.97	41.75	7.83	2.37
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	374.89	79.67	8.24	1.74
neuroectodermal tumor cell line:TASK1	10774-110F9	615.25	79.30	16.10	3.42
neuroepithelioma cell line:SK-N-MC	10728-110A8	185.64	89.01	9.54	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	252.59	48.44	9.05	1.86
neutrophil PMN, donor1	12133-128D9	0.00	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	159.37	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	142.06	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	956.71	66.63	8.46	3.04
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	157.70	371.44	2.40	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	259.05	44.88	7.69	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	199.18	41.78	10.51	0.26
nucleus accumbens, adult, pool1	10037-101F1	68.90	27.18	2.34	0.47
occipital cortex - adult, donor10196	10172-103C1	67.99	57.69	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	82.12	18.25	0.54	0.27
occipital cortex, newborn, donor10223	10355-105E4	88.07	36.39	4.73	1.46
occipital lobe, adult, donor1	10076-102A4	120.44	55.37	4.99	0.79
occipital lobe, fetal, donor1	10073-102A1	571.13	55.35	4.29	3.86
occipital pole, adult, pool1	10036-101E9	35.16	28.86	1.26	0.39
olfactory region, adult	10195-103E6	69.54	21.40	4.20	1.34
optic nerve, donor1	10277-104E7	164.09	40.02	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	143.87	26.20	5.47	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	348.82	79.68	16.21	1.10
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	206.74	39.96	6.43	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	391.34	50.82	9.70	3.93
osteoclastoma cell line:Hs 706.T	10704-109H2	179.61	29.69	3.23	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	743.73	64.47	12.15	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	185.76	25.45	7.00	0.64
ovary, adult, pool1	10020-101D2	271.40	18.26	3.14	1.40
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	161.32	25.66	7.70	1.10
pancreas, adult, donor1	10049-101G4	1009.31	54.56	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	456.76	37.46	2.52	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	156.38	35.09	5.45	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	256.16	27.82	4.31	0.50
paracentral gyrus, adult, pool1	10035-101E8	45.49	34.23	1.19	0.18
parietal cortex, adult, donor10258	10373-105G4	77.07	34.50	4.40	2.94
parietal lobe - adult, donor10196	10171-103B9	64.89	36.68	3.76	0.00
parietal lobe, adult, donor10252	10157-103A4	60.14	14.54	2.00	0.00
parietal lobe, adult, pool1	10034-101E7	48.91	30.23	1.23	0.44
parietal lobe, fetal, donor1	10072-101I9	482.98	53.34	3.88	3.88
parietal lobe, newborn, donor10223	10356-105E5	103.56	28.04	4.11	1.12
parotid gland, adult	10199-103F1	415.01	128.88	1.85	0.00
penis, adult	10200-103F2	225.05	25.24	3.22	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	382.10	52.25	5.76	2.42
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	213.15	55.07	5.39	0.73
pineal gland - adult, donor10196	10179-103C8	37.41	18.06	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	53.30	30.20	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	57.06	43.27	1.88	0.00
pituitary gland - adult, donor10196	10180-103C9	110.29	68.80	3.04	0.00
pituitary gland, adult, donor10252	10162-103A9	95.90	55.25	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	116.62	96.19	0.00	0.00
placenta, adult, pool1	10021-101D3	100.30	44.18	2.15	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	393.71	56.68	11.65	1.46
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	181.16	33.93	3.74	0.47
pons, adult, pool1	10033-101E6	53.02	52.76	1.46	0.00
postcentral gyrus, adult, pool1	10032-101E5	57.62	36.35	1.92	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	33.46	4.18	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	2247.28	82.62	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	2042.02	23.47	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	226.07	72.54	6.12	0.58
prostate cancer cell line:PC-3	10439-106E7	272.80	49.37	9.98	0.73
prostate, adult, pool1	10022-101D4	175.76	19.32	0.82	0.27
putamen, adult, donor10196	10176-103C5	142.35	27.62	13.22	1.42
putamen, adult, donor10252	10152-102I8	192.15	33.33	11.76	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	106.00	48.08	9.84	9.84
putamen, adult, donor10258, tech_rep2	10372-105G3	101.24	37.45	5.56	3.38
putamen, newborn, donor10223	10365-105F5	239.14	50.98	9.75	3.00
rectal cancer cell line:TT1TKB	10469-106I1	435.82	18.62	6.69	1.16
rectum, fetal, donor1	10067-101I4	349.14	55.64	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	54.91	41.13	0.64	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	51.36	7.87	1.24	0.41
retina, adult, pool1	10030-101E3	83.00	26.54	1.29	0.30
retinoblastoma cell line:Y79	10475-106I7	1234.84	124.45	16.11	3.38
rhabdomyosarcoma cell line:KYM-1	10787-110H4	257.45	74.75	11.68	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	670.94	167.60	6.19	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	257.67	24.25	9.09	1.52
salivary acinar cells, donor1	11771-123I7	381.50	31.40	6.80	1.29
salivary acinar cells, donor2	11772-123I8	378.50	17.35	3.58	2.62
salivary acinar cells, donor3	11773-123I9	254.23	7.94	4.63	0.66
salivary gland, adult, pool1	10093-102C3	131.55	98.95	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	293.15	30.35	5.99	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	357.95	38.67	5.76	0.47
seminal vesicle, adult	10201-103F3	268.77	22.75	2.65	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	256.53	42.51	8.75	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	113.23	47.81	3.27	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	128.45	84.30	4.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	239.09	35.86	6.58	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	189.00	46.64	9.39	0.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	672.61	66.71	7.10	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	458.94	39.01	11.35	0.00
skeletal muscle, adult, pool1	10023-101D5	492.70	53.25	5.52	0.84
skeletal muscle, fetal, donor1	10066-101I3	470.35	44.22	3.02	1.01
skin, adult, donor1	10074-102A2	413.90	33.93	6.79	0.00
skin, fetal, donor1	10065-101I2	388.20	42.29	6.31	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	184.77	101.06	7.67	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	310.16	67.14	16.08	4.10
small cell lung carcinoma cell line:DMS 144	10841-111E4	262.72	79.60	8.10	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	359.32	123.79	6.92	1.48
small cell lung carcinoma cell line:NCI-H82	10842-111E5	194.47	145.41	0.80	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	125.08	41.19	6.32	0.00
small intestine, adult, pool1	10024-101D6	290.01	44.19	2.03	0.12
small intestine, fetal, donor1	10064-101I1	606.13	66.58	3.93	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	203.62	35.39	12.31	0.51
smooth muscle, adult, pool1	10048-101G3	222.79	13.44	1.55	0.26
somatostatinoma cell line:QGP-1	10781-110G7	272.85	37.79	8.58	3.22
spinal cord - adult, donor10196	10181-103D1	170.91	28.22	1.61	0.23
spinal cord, adult, donor10252	10159-103A6	140.36	19.32	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	153.58	67.80	3.46	2.08
spinal cord, fetal, donor1	10056-101H2	146.97	55.50	3.66	1.22
spinal cord, newborn, donor10223	10359-105E8	147.87	50.97	4.59	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	238.52	43.46	7.92	1.19
spleen, adult, pool1	10025-101D7	239.10	18.39	2.20	0.22
spleen, fetal, pool1	10044-101F8	157.40	17.40	1.43	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	318.30	47.20	9.32	1.14
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	112.60	16.90	3.42	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	101.69	45.78	3.49	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	326.04	43.39	16.03	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	180.09	47.84	7.09	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	321.09	88.11	11.01	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	274.57	31.31	8.46	0.85
stomach, fetal, donor1	10062-101H8	376.99	59.81	4.27	1.07
submaxillary gland, adult	10202-103F4	297.94	89.44	1.71	2.85
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	121.09	19.11	0.62	0.21
substantia nigra, adult, donor10258	10371-105G2	75.52	41.38	4.66	1.03
substantia nigra, newborn, donor10223	10358-105E7	102.45	27.56	3.53	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	350.78	72.91	11.23	1.15
temporal lobe, adult, pool1	10031-101E4	60.02	31.62	1.86	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	423.09	37.75	4.27	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	383.72	28.57	6.15	3.08
tenocyte, donor1	11763-123H8	234.94	37.70	7.33	3.14
tenocyte, donor2	11765-123I1	217.46	27.09	2.67	2.67
tenocyte, donor3	11768-123I4	271.33	43.74	8.15	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	236.75	158.40	9.01	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	341.44	98.04	8.63	1.08
teratocarcinoma cell line:PA-1	10807-111A6	178.22	114.37	7.28	1.55
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	286.52	106.26	12.44	2.29
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	350.94	105.89	5.29	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	392.41	68.38	4.69	1.42
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	358.27	154.71	12.05	1.63
testis, adult, pool1	10026-101D8	157.84	43.06	3.11	0.32
testis, adult, pool2	10096-102C6	110.06	68.56	0.90	1.35
thalamus - adult, donor10196	10168-103B6	87.21	46.37	2.21	1.10
thalamus, adult, donor10252	10154-103A1	111.59	22.04	1.25	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	76.98	52.35	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	103.75	44.63	2.64	0.33
thalamus, newborn, donor10223	10366-105F6	99.53	41.42	6.33	2.30
throat, adult	10209-103G2	332.31	42.94	6.24	0.00
throat, fetal, donor1	10061-101H7	205.68	36.87	1.83	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	399.05	64.99	24.44	1.39
thymus, adult, pool1	10027-101D9	261.06	23.86	2.68	0.89
thymus, fetal, pool1	10043-101F7	175.08	21.20	1.97	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	300.36	94.00	11.04	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	334.14	62.16	6.84	1.82
thyroid, adult, pool1	10028-101E1	189.43	39.19	1.77	0.19
thyroid, fetal, donor1	10060-101H6	115.75	42.71	1.32	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	98.55	9.24	0.00	0.00
tongue, adult	10203-103F5	333.98	66.98	11.63	0.70
tongue, fetal, donor1	10059-101H5	266.41	78.03	1.97	1.18
tonsil, adult, pool1	10047-101G2	274.08	28.85	2.70	0.90
trachea, adult, pool1	10029-101E2	194.11	22.99	2.86	0.49
trachea, fetal, donor1	10058-101H4	255.44	43.86	3.85	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	279.52	62.35	17.71	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	225.73	92.10	7.90	0.81
transitional-cell carcinoma cell line:JMSU1	10492-107B6	591.96	51.86	6.74	1.10
tridermal teratoma cell line:HGRT	10694-109G1	156.01	24.73	9.51	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	298.22	46.64	2.37	1.95
umbilical cord, fetal, donor1	10057-101H3	208.65	37.56	6.26	4.17
uterus, adult, pool1	10100-102D1	155.61	21.50	1.19	1.19
uterus, fetal, donor1	10055-101H1	301.01	45.56	3.07	2.56
vagina, adult	10204-103F6	308.24	9.69	2.58	0.00
vein, adult	10191-103E2	356.85	19.73	3.07	1.32
xeroderma pigentosum b cell line:XPL 17	10563-108A5	362.10	26.17	5.34	4.27